Affiliation:
1. Universidade Federal do Ceará, Brazil; Hospital Monte Klinikum, Brazil
2. Hospital Universitário Walter Cantídio, Brazil
3. Universidade Federal do Ceará, Brazil
Abstract
Objective: to analyze the evidence available in the literature about the lowest necessary dose of heparin to maintain the patency of the totally implanted central venous catheter in adult cancer patients. Method: an integrative literature review, carried out in the following databases: Literatura Latino-Americana e do Caribe em Ciências de Saúde, Sciverse Scopus, Web of Science, Cumulative Index to Nursing and Allied Health Literature, Cochrane Central Register of Controlled Trials, including thirteen studies. Results: the evidence showed that the dose of heparin (300 IU/ml) is the most used in maintaining the patency of the totally implanted central venous catheter. Conclusion: according to the selected studies, the lowest dose of heparin found in maintaining the patency of the totally implanted central venous catheter in cancer patients was 10 UN/ml with a volume of 5 ml of the heparin solution.
Reference44 articles.
1. Extending the interval for port-a-cath maintenance;Girda E;Modern Chemother,2013
2. Validation of standard operating procedures in nursing care of patients with totally implanted catheters;Honório RPP;Rev Bras Enferm,2011
3. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals;Palese A;Eur J Oncol Nurs,2014
4. Infusion nursing standards of practice;J Infus Nurs,2016
5. Occlusion management guideline for central venous access devices (CVADs);Hill J;Vasc Access,2013
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献